Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$0.64 - $1.03 $3,114 - $5,013
-4,867 Reduced 79.71%
1,239 $1,000
Q1 2023

Apr 27, 2023

BUY
$0.46 - $0.77 $2,808 - $4,701
6,106 New
6,106 $4,000
Q2 2022

Aug 03, 2022

SELL
$0.54 - $1.41 $1,368 - $3,574
-2,535 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$1.4 - $5.15 $22,650 - $83,321
-16,179 Reduced 86.45%
2,535 $3,000
Q4 2021

Feb 23, 2022

BUY
$4.27 - $6.97 $68,631 - $112,028
16,073 Added 608.6%
18,714 $97,000
Q3 2021

Oct 28, 2021

BUY
$5.31 - $8.25 $13,774 - $21,400
2,594 Added 5519.15%
2,641 $21,000
Q2 2021

Aug 12, 2021

SELL
$6.81 - $9.23 $106,392 - $144,200
-15,623 Reduced 99.7%
47 $0
Q1 2021

Apr 26, 2021

BUY
$7.99 - $15.0 $42,602 - $79,980
5,332 Added 51.58%
15,670 $130,000
Q4 2020

Feb 02, 2021

BUY
$7.04 - $11.7 $59,621 - $99,087
8,469 Added 453.13%
10,338 $78,000
Q3 2020

Oct 14, 2020

BUY
$9.98 - $18.04 $18,652 - $33,716
1,869 New
1,869 $19,000
Q2 2020

Jul 13, 2020

SELL
$7.49 - $15.16 $214,783 - $434,728
-28,676 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$4.62 - $18.74 $132,483 - $537,388
28,676 New
28,676 $238,000
Q4 2018

Jan 16, 2019

SELL
$10.42 - $21.94 $26,571 - $55,947
-2,550 Closed
0 $0
Q3 2018

Oct 23, 2018

SELL
$20.4 - $24.6 $243,290 - $293,379
-11,926 Reduced 82.38%
2,550 $58,000
Q2 2018

Jul 30, 2018

BUY
$19.02 - $24.95 $275,333 - $361,176
14,476 New
14,476 $322,000
Q1 2018

Apr 26, 2018

SELL
$22.55 - $29.9 $177,536 - $235,402
-7,873 Closed
0 $0
Q4 2017

Jan 10, 2018

SELL
$18.0 - $30.0 $105,354 - $175,590
-5,853 Reduced 42.64%
7,873 $206,000
Q3 2017

Oct 25, 2017

BUY
$21.1 - $25.15 $289,618 - $345,208
13,726
13,726 $308,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.